YaleABNLab retweeted
Had such a great time at my first @CPDDorg ✨
This chapter is over, but the journey continues. Excited to keep exploring what drives cannabis use and how these motivations shape people’s experiences. @YalePsych @YaleABNLab @anahitabassir #CPDD2026#cannabisuse
YaleABNLab retweeted
Why people with psychosis use cannabis more than general population? My amazing postdoc, @YaldaFarahmand, presented our study trying to answer this question at #CPDD2026.
@YaleABNLab – at West Haven, CT
I’m honored to present our study on cannabis motivations at the @CPDDorg this year! I’d be excited to meet everyone at the poster sessions tomorrow! @YalePsych @YaleABNLab @anahitabassir
#cannabismotivation#YalePsychiatry#CPDD2026
YaleABNLab retweeted
MEAI is a non-hallucinergic psychedelic with chemical structure similar to MDMA.
In this review from our lab, we discussed the potential Therapeutic use if MEAI in the treatment of alcohol use disorder (AUD).
#psychedelics
#MDMA
#MEAI
@YaleABNLab
@YalePsych – at West Haven, CT
YaleABNLab retweeted
We will discuss findings and lessons learned from our ongoing first-in-human clinical trial of MEAI in healthy participants and individuals with alcohol use disorder.
@YaleABNLab
@YalePsych – at West Haven, CT
Our team is currently seeking adults who heavily drink alcohol, ages 21 to 65, for a psychedelic clinical trial. Participants are eligible for compensation up to $1,650. If interested, please call us back at 203-932-5711 x1-5314 or 203-974-7324!
Our team is currently seeking adults who heavily drink alcohol, ages 21 to 65, for a psychedelic clinical trial. Participants are eligible for compensation up to $1,675. If interested, please call us back at 203-932-5711 x1-5314 or 203-974-7324
YaleABNLab retweeted
Excited to receive #ACNP senior researcher travel award!
Looking forward to a wonderful meeting #acnp2026 in #Bahamas (Jan 2026)!
@YalePsych
@YaleABNLab
@ACNPorg
YaleABNLab retweeted
Dr. Anahita Bassir Nia focuses on translational research on the neurobiology of stress-related disorders and addiction, with a main focus on cannabinoids and psychedelics 🍄💊 / @anahitabassir
Our team is currently seeking healthy volunteers age 18-60 for a psychedelic clinical trial located in New Haven, CT. Participants are eligible for compensation up to $625. If interested, please call us back at 203-974-7324!
Read our latest #research on the contribution of #CBD in treatment for #opioid #addiction, published with @WileyGlobal in Addiction Biology on behalf of @SSA_Addiction. Read here: doi.org/10.1111/adb.70047.
Yale ABNLab will be presenting at @SOBP 2025 in Toronto this week! Please see below for more details! #Neuroscience #NeuroPsych #PsychResearch #2025SOBP
Read our latest #research on the contribution of #psychotherapy to #psychedelic treatment for #opioid #addiction, published with @SpringerNature in Current Addiction Reports. Read here: rdcu.be/eaAo9
A pre #acnp2024 #hike in #Sedona. I hiked #cathedralrock, #littlehorse, and #chapeltrail. I had underestimated #arizona sun! But the trails were wonderful!
@ACNPorg
@YaleABNLab
Hey @acnp. I am Anahita, an assistant professor @YalePsych. I study the #endocannabinoid system and #psychedelics in #addiction and #ptsd.
@YaleABNLab.
Looking forward to the next three days! #acnp2024
Another poster from @YaleABNLab with @harpaz_l.
@AMohammadaghaei will present #cannabinoid receptor type 1 availability in #ptsd with #childhood_trauma today at 5pm.
#acnp2024
@ACNPorg
@YalePsych
I will present the results of my NIDA funded study on CB1R availability in opioid use disorder @ACNPorg.
#ACNP2024
@YalePsych
@YaleABNLab
























